-
Mashup Score: 2Advancing ATTR Drug Development - 10 month(s) ago
The first generation of drug approvals in #ATTR #amyloidosis has reshaped the research landscape. This month’s hybrid #AmyloidosisForum will consider how to effectively design trials against a backdrop of treatments that slow progression of the disease.
Source: The Amyloidosis ForumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Advancing ATTR Drug Development - 10 month(s) ago
The first generation of drug approvals in #ATTR #amyloidosis has reshaped the research landscape. This month’s hybrid #AmyloidosisForum will consider how to effectively design trials against a backdrop of treatments that slow progression of the disease.
Source: The Amyloidosis ForumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
We will post a recording of today's sessions to our website as soon as possible in the coming weeks. https://t.co/R7suiCWCGW
-
-
Mashup Score: 3Advancing ATTR Drug Development - 10 month(s) ago
The first generation of drug approvals in #ATTR #amyloidosis has reshaped the research landscape. This month’s hybrid #AmyloidosisForum will consider how to effectively design trials against a backdrop of treatments that slow progression of the disease.
Source: The Amyloidosis ForumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
📆🔬💊 We're all set up for tomorrow's #AmyloidosisForum at FDA's White Oak campus (and online via Zoom). All day discussions around #ATTR #amyloidosis drug development. Don't miss out! Register now: https://t.co/R7suiCWCGW https://t.co/KDjkmYmnd4
-
-
Mashup Score: 1Advancing ATTR Drug Development - 10 month(s) ago
The first generation of drug approvals in #ATTR #amyloidosis has reshaped the research landscape. This month’s hybrid #AmyloidosisForum will consider how to effectively design trials against a backdrop of treatments that slow progression of the disease.
Source: The Amyloidosis ForumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
We're on our way to DC for tomorrow's #AmyloidosisForum. Can't wait to work with over 60 speakers and push #ATTR #amyloidosis drug development forward! https://t.co/R7suiCWCGW https://t.co/RqssmDmXZ6
-
-
Mashup Score: 0Advancing ATTR Drug Development - 10 month(s) ago
The first generation of drug approvals in #ATTR #amyloidosis has reshaped the research landscape. This month’s hybrid #AmyloidosisForum will consider how to effectively design trials against a backdrop of treatments that slow progression of the disease.
Source: The Amyloidosis ForumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
As we get ready for Wednesday's #AmyloidosisForum, we want to take a moment to thank all the supporters that have helped make these conversations about the future of #ATTR #amyloidosis drug development possible! https://t.co/R7suiCWCGW https://t.co/hkiUhzUwTU
-
-
Mashup Score: 4Advancing ATTR Drug Development - 11 month(s) ago
The first generation of drug approvals in #ATTR #amyloidosis has reshaped the research landscape. This month’s hybrid #AmyloidosisForum will consider how to effectively design trials against a backdrop of treatments that slow progression of the disease.
Source: The Amyloidosis ForumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The first generation of drug approvals in #ATTR #amyloidosis has reshaped the research landscape. This month's #AmyloidosisForum will consider how to effectively design trials against a backdrop of treatments that slow progression of the disease. https://t.co/R7suiCWCGW
-
-
Mashup Score: 0Home - The Amyloidosis Forum - 1 year(s) ago
Formed in 2019, The Amyloidosis Forum has been developed through a public-private partnership between the Amyloidosis Research Consortium (ARC) and the US Food and Drug Administration (FDA). The overarching goal of the Forum is to optimize innovation and accelerate the advancement of new therapeutics by addressing scientific gaps and needs through the conduct of mutually beneficial scientific…
Source: The Amyloidosis ForumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Learn more about our work with FDA, the #AmyloidosisForum, here: https://t.co/cCtzX4sdBL
-
-
Mashup Score: 0Development of Imaging Endpoints - 11/18 - 1 year(s) ago
Exploring potential pathways for development of imaging endpoints for clinical trials in AL and ATTR amyloidosis.
Source: The Amyloidosis ForumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
A big thank you to all the speakers and panelists who made our recent #Amyloidosis Forum exploring imaging in amyloidosis such a successful meeting, and to the patients who participated in ARC's patient poll leading up to the event. Watch the video here: https://t.co/gqzpEobd2g
-
-
Mashup Score: 4Development of Imaging Endpoints - 11/18 - 1 year(s) ago
Exploring potential pathways for development of imaging endpoints for clinical trials in AL and ATTR amyloidosis.
Source: The Amyloidosis ForumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
A huge THANK YOU to all the speakers and participants who made todays #AmyloidosisForum an amazing event laying the groundwork for future uses of imaging in #amyloidosis https://t.co/Ck8RIbmUzm https://t.co/D544wI1xRG
-
-
Mashup Score: 8Development of Imaging Endpoints - 11/18 - 1 year(s) ago
Exploring potential pathways for development of imaging endpoints for clinical trials in AL and ATTR amyloidosis.
Source: The Amyloidosis ForumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
An exciting session at #AmyloidosisForum begins now, hearing from multiple departments at FDA, with representatives from EMA and MHRA as well, sharing the regulatory perspective on imaging and #amyloidosis from around the world. Watch online: https://t.co/Ck8RIbmUzm https://t.co/DS1RyffBIQ
-
Happening Now: the second half of our sessions for the #AmyloidosisForum, including lively discussions outlining how imaging can be used in clinical outcomes for #amyloidosis, moderated by Preston Dunnmon Watch online here: https://t.co/Ck8RIbmUzm https://t.co/2Jl9AgwBmv
-
We're delighted last week's #AmyloidosisForum delivered so many great conversations about the future of #ATTR #amyloidosis drug development. We're already hard at work turning those conversations into action! Watch the entire event yourself here: https://t.co/crQV0os656